Victory Park Funds Newly Launched Enteris BioPharma
Victory Park Capital announced it has funded newly-launched portfolio company Enteris BioPharma, a maker of oral delivery peptides and small molecule therapeutics.
Victory Park Capital announced it has funded newly-launched portfolio company Enteris BioPharma, a maker of oral delivery peptides and small molecule therapeutics.
Victory Park Capital said it provided a $25 million credit facility for Chicago-based AvantCredit. The asset management firm also said it participated in the lending company’s equity round led by August Capital.
Kabbage, an online provider of small businesses financing, closed a $75 million credit facility. Victory Park Capital led the debt financing, while existing equity investor Thomvest Ventures also contributed.
Victory Park hired Jordan Allen to its newly established chief operating officer position. He will also serve as principal. Allen previously served as co-head, chief operating officer and CFO of Man Investments, North America and president and partner of HFR Asset Management.